Suppr超能文献

结构复杂的八面体金属配合物作为高选择性的蛋白激酶抑制剂。

Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors.

机构信息

Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Strasse, 35043 Marburg, Germany.

出版信息

J Am Chem Soc. 2011 Apr 20;133(15):5976-86. doi: 10.1021/ja1112996. Epub 2011 Mar 29.

Abstract

The generation of synthetic compounds with exclusive target specificity is an extraordinary challenge of molecular recognition and demands novel design strategies, in particular for large and homologous protein families such as protein kinases with more than 500 members. Simple organic molecules often do not reach the necessary sophistication to fulfill this task. Here, we present six carefully tailored, stable metal-containing compounds in which unique and defined molecular geometries with natural-product-like structural complexity are constructed around octahedral ruthenium(II) or iridium(III) metal centers. Each of the six reported metal compounds displays high selectivity for an individual protein kinase, namely GSK3α, PAK1, PIM1, DAPK1, MLCK, and FLT4. Although being conventional ATP-competitive inhibitors, the combination of the unusual globular shape and rigidity characteristics, of these compounds facilitates the design of highly selective protein kinase inhibitors. Unique structural features of the octahedral coordination geometry allow novel interactions with the glycine-rich loop, which contribute significantly to binding potencies and selectivities. The sensitive correlation between metal coordination sphere and inhibition properties suggests that in this design, the metal is located at a "hot spot" within the ATP binding pocket, not too close to the hinge region where globular space is unavailable, and at the same time not too far out toward the solvent where the octahedral coordination sphere would not have a significant impact on potency and selectivity. This study thus demonstrates that inert (stable) octahedral metal complexes are sophisticated structural scaffolds for the design of highly selective chemical probes.

摘要

生成具有独特靶向特异性的合成化合物是分子识别的一项非凡挑战,需要新的设计策略,特别是对于蛋白质激酶等具有 500 多个成员的大型和同源蛋白家族。简单的有机分子通常无法达到完成这项任务所需的精细程度。在这里,我们提出了六个精心设计的稳定含金属化合物,其中围绕八面体钌(II)或铱(III)金属中心构建了具有天然产物样结构复杂性的独特和定义明确的分子几何形状。报告的六个金属化合物中的每一个都对单个蛋白激酶表现出高度选择性,即 GSK3α、PAK1、PIM1、DAPK1、MLCK 和 FLT4。尽管它们是常规的 ATP 竞争性抑制剂,但这些化合物的不寻常球形和刚性特征的组合有助于设计高度选择性的蛋白激酶抑制剂。八面体配位几何的独特结构特征允许与富含甘氨酸的环形成新的相互作用,这对结合亲和力和选择性有很大贡献。金属配位球与抑制特性之间的敏感相关性表明,在这种设计中,金属位于 ATP 结合口袋的“热点”处,既不太靠近铰链区域,那里没有球形空间,也不太远离溶剂,在那里八面体配位球不会对效力和选择性产生重大影响。因此,这项研究表明,惰性(稳定)八面体金属配合物是设计高度选择性化学探针的复杂结构支架。

相似文献

8
Iridium complex with antiangiogenic properties.具有抗血管生成特性的铱配合物。
Angew Chem Int Ed Engl. 2010 May 17;49(22):3839-42. doi: 10.1002/anie.201000682.

引用本文的文献

3
Metals in Cancer Research: Beyond Platinum Metallodrugs.癌症研究中的金属:超越铂类金属药物
ACS Cent Sci. 2024 Feb 7;10(2):242-250. doi: 10.1021/acscentsci.3c01340. eCollection 2024 Feb 28.
6
Transition metals in angiogenesis - A narrative review.血管生成中的过渡金属——一篇叙述性综述。
Mater Today Bio. 2023 Aug 3;22:100757. doi: 10.1016/j.mtbio.2023.100757. eCollection 2023 Oct.
10
Metal Complexes for Therapeutic Applications.用于治疗应用的金属配合物。
Trends Chem. 2021 Jul;3(7):523-534. doi: 10.1016/j.trechm.2021.03.006. Epub 2021 Apr 14.

本文引用的文献

4
Organometallic anticancer compounds.有机金属抗癌化合物。
J Med Chem. 2011 Jan 13;54(1):3-25. doi: 10.1021/jm100020w. Epub 2010 Nov 15.
7
Targeted covalent drugs of the kinase family.靶向激酶家族的共价药物。
Curr Opin Chem Biol. 2010 Aug;14(4):475-80. doi: 10.1016/j.cbpa.2010.06.168. Epub 2010 Jul 6.
8
Iridium complex with antiangiogenic properties.具有抗血管生成特性的铱配合物。
Angew Chem Int Ed Engl. 2010 May 17;49(22):3839-42. doi: 10.1002/anie.201000682.
9
Features and development of Coot.Coot的特点与发展
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. doi: 10.1107/S0907444910007493. Epub 2010 Mar 24.
10
The art of the chemical probe.化学探针的技术
Nat Chem Biol. 2010 Mar;6(3):159-161. doi: 10.1038/nchembio.296.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验